Literature DB >> 16199931

Sphingosine 1-phosphate induces alpha-smooth muscle actin expression in lung fibroblasts via Rho-kinase.

Yoshiko Urata1, Yoshihiro Nishimura, Tetsuaki Hirase, Mitsuhiro Yokoyama.   

Abstract

Transformation of fibroblasts into myofibroblasts is an important phenomenon that contributes to airway remodeling in bronchial asthma. Although several articles have recently indicated that a bioactive lysosphingolipid sphingosine 1-phosphate (S1P) plays roles in the pathogenesis of bronchial asthma, the role of S1P in the remodeling process is poorly understood. In the present study, we examined the effects of S1P on alpha-smooth muscle actin (SMA) expression and the morphology in lung fibroblasts. S1P stimulated the expression of alpha-SMA in a human lung fibroblast cell line WI38 that expresses EDG/S1P receptors. These processes were inhibited by Y-27632, but not by pertussis toxin. These results suggest that S1P induces a phenotypic change of lung fibroblasts via Rho-kinase that may lead to airway remodeling.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16199931

Source DB:  PubMed          Journal:  Kobe J Med Sci        ISSN: 0023-2513


  14 in total

1.  Immunomodulator FTY720 induces myofibroblast differentiation via the lysophospholipid receptor S1P3 and Smad3 signaling.

Authors:  Christina D Keller; Pilar Rivera Gil; Markus Tölle; Markus van der Giet; Jerold Chun; Heinfried H Radeke; Monika Schäfer-Korting; Burkhard Kleuser
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

2.  Role of host sphingosine kinase 1 in the lung response against Cryptococcosis.

Authors:  Travis McQuiston; Chiara Luberto; Maurizio Del Poeta
Journal:  Infect Immun       Date:  2010-03-01       Impact factor: 3.441

3.  Sphingosine 1-phosphate (S1P) receptor agonists mediate pro-fibrotic responses in normal human lung fibroblasts via S1P2 and S1P3 receptors and Smad-independent signaling.

Authors:  Katrin Sobel; Katalin Menyhart; Nina Killer; Bérengère Renault; Yasmina Bauer; Rolf Studer; Beat Steiner; Martin H Bolli; Oliver Nayler; John Gatfield
Journal:  J Biol Chem       Date:  2013-04-15       Impact factor: 5.157

4.  Sphingosine-1-phosphate receptor-2 regulates expression of smooth muscle alpha-actin after arterial injury.

Authors:  Allison D Grabski; Takuya Shimizu; Jessie Deou; William M Mahoney; Michael A Reidy; Guenter Daum
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-07-16       Impact factor: 8.311

Review 5.  Sphingosine-1-phosphate receptor signalling in the heart.

Authors:  Christopher K Means; Joan Heller Brown
Journal:  Cardiovasc Res       Date:  2009-03-12       Impact factor: 10.787

6.  Sphingosine 1-phosphate potentiates human lung fibroblast chemotaxis through the S1P2 receptor.

Authors:  Mitsu Hashimoto; Xingqi Wang; Lijun Mao; Tetsu Kobayashi; Shin Kawasaki; Naoyoshi Mori; Myron L Toews; Hui Jung Kim; D Roselyn Cerutis; Xiangde Liu; Stephen I Rennard
Journal:  Am J Respir Cell Mol Biol       Date:  2008-03-26       Impact factor: 6.914

7.  Sphingosine-1-phosphate and sphingosine kinase are critical for transforming growth factor-beta-stimulated collagen production by cardiac fibroblasts.

Authors:  Nicole Gellings Lowe; James S Swaney; Kelli M Moreno; Roger A Sabbadini
Journal:  Cardiovasc Res       Date:  2009-02-19       Impact factor: 10.787

8.  Anti-sphingosine-1-phosphate monoclonal antibodies inhibit angiogenesis and sub-retinal fibrosis in a murine model of laser-induced choroidal neovascularization.

Authors:  Sergio Caballero; James Swaney; Kelli Moreno; Aqeela Afzal; Jennifer Kielczewski; Glenn Stoller; Amy Cavalli; William Garland; Geneviève Hansen; Roger Sabbadini; Maria B Grant
Journal:  Exp Eye Res       Date:  2008-08-06       Impact factor: 3.467

9.  Transforming growth factor-beta1 induces transdifferentiation of myoblasts into myofibroblasts via up-regulation of sphingosine kinase-1/S1P3 axis.

Authors:  Francesca Cencetti; Caterina Bernacchioni; Paola Nincheri; Chiara Donati; Paola Bruni
Journal:  Mol Biol Cell       Date:  2010-01-20       Impact factor: 4.138

10.  Administration of JTE013 abrogates experimental asthma by regulating proinflammatory cytokine production from bronchial epithelial cells.

Authors:  Tomomi Terashita; Kazuyuki Kobayashi; Tatsuya Nagano; Yoshitaka Kawa; Daisuke Tamura; Kyosuke Nakata; Masatsugu Yamamoto; Motoko Tachihara; Hiroshi Kamiryo; Yoshihiro Nishimura
Journal:  Respir Res       Date:  2016-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.